Dr. Sarah Rose Torok

Pharmacist



  
  4614 N Ih 35, Austin
Texas, 78751-3401

 512-978-9139   
Dr. Sarah Rose Torok is a pharmacist in Austin, Texas. Patients can reach her at 4614 N Ih 35, Austin or contact her on 512-978-9139. Active license number of Dr. Sarah Rose Torok is 63116 for Pharmacist in Texas.
Dr. Sarah Rose Torok is


Complete Profile:
Dr. Sarah Rose Torok speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name: Dr. Sarah Rose Torok
Specialization: Pharmacist
Credentials:PHARMD, RPH, AAHIV
Gender:Female
Location:4614 N Ih 35, Austin,
Texas, 78751-3401
Phone:512-978-9139
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Sarah Rose Torok are as mentioned below.
NPI Number: 1750252300
NPI Enumeration Date: 16 Sep, 2025
NPI Last Update On: 17 Apr, 2026

Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Sarah Rose Torok are as mentioned below.
SpecializationLicense NumberStateStatus
Pharmacist 63116TexasPrimary
Pharmacist 63116TexasSecondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 4614 N Ih 35,
Austin, Texas
Zip: 78751-3401
Phone Number: 512-788-1276
Patients can reach Dr. Sarah Rose Torok at 4614 N Ih 35, Austin, Texas or can call on phone at 512-978-9139.

Comments/ Reviews:
Read all the reviews posted for Dr. Sarah Rose Torok below. You may also share your own experience with Dr. Sarah Rose Torok. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 June, 2026.